Moolec Science (NASDAQ:MLEC) Stock Rating Upgraded by Wall Street Zen

Moolec Science (NASDAQ:MLEC) was upgraded by analysts at Wall Street Zen to a “sell” rating in a note issued to investors on Saturday.

Moolec Science Price Performance

Shares of MLEC opened at $13.30 on Friday. The company has a market capitalization of $9.71 million, a P/E ratio of -0.40 and a beta of -0.46. Moolec Science has a one year low of $3.08 and a one year high of $157.05. The business’s 50 day simple moving average is $6.93 and its 200-day simple moving average is $11.65.

Institutional Investors Weigh In On Moolec Science

A hedge fund recently bought a new stake in Moolec Science stock. Citadel Advisors LLC purchased a new position in Moolec Science SA (NASDAQ:MLEC) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm purchased 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned about 0.90% of Moolec Science as of its most recent SEC filing. 0.07% of the stock is owned by institutional investors and hedge funds.

Moolec Science Company Profile

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.